Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD
Medtronic Cardiac Rhythm Disease Management · Decision date Sep 25, 2026
What did the FDA decide?
FDA database entry P980016/S965 records a 30-day notice for the Cobalt MRI ICD, Cobalt XT MRI ICD, and Crome MRI ICD. The stated purpose is updates to visual inspection criteria for anode components at the Medtronic Energy and Component Center (MECC). The supplement type is a 30-Day Notice, and the supplement reason is listed as a process change involving manufacturer, sterilizer, packager, or supplier.
This entry does not represent a new approval of the device system. The original PMA identifier P980016 establishes the parent application, while S965 is a supplement limited to the described manufacturing process change. The source statement reports the intended scope of the notice; it does not independently demonstrate safety or clinical effectiveness. Specific details about what the updated inspection criteria require are not present in the available fields.
FDA approval order statement
updates to visual inspection criteria for anode components at the Medtronic Energy and Component Center (MECC)
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 25, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P980016/S965
- Regulatory pathway
- PMA supplement
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980016 · Original PMA
VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS
P980016/S965 received
Application receipt date recorded by FDA.
P980016/S965 · FDA decision
30-Day Notice
P980016/S966 · Related supplement
Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I
P980016/S967 · Related supplement
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD
P980016/S964 · Related supplement
Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I
Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA approval | Oct 9, 1998 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 5, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cardiac Rhythm Disease Management
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P980016/S965
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




